Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice

Molecular Therapy

Volumn 16, Issue 10, 2008, Pages 1688-1694

  Li, Qiuhong ^a   Dinculescu, Astra ^a   Shan, Zhiying ^b   Miller, Rehae ^a   Pang, Jijing ^a   Lewin, Alfred S ^b   Raizada, Mohan K ^b   Hauswirth, William W ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSAGE FORM COMPARISON; EPITHELIUM CELL; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RETINA NERVE CELL; RNA INTERFERENCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; BLOTTING, WESTERN; CHOROIDAL NEOVASCULARIZATION; CYTOCHROME B GROUP; DEPENDOVIRUS; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL PIGMENT EPITHELIUM; RNA, SMALL INTERFERING;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 54849175900     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.164     Document Type: Article

References (50)

1. Klein, R (2007). Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 14: 184-187.
2. Smith, W, Assink, J, Klein, R, Mitchell, P, Klaver, CC, Klein, BE et al. (2001). Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108: 697-704.
3. Seddon, JM and Chen, CA (2004). The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 44: 17-39.
4. Beatty, S, Koh, H, Phil, M, Henson, D and Boulton, M (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
5. Miceli, MV, Liles, MR and Newsome, DA (1994). Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 214: 242-249.
6. Yang, D, Elner, SG, Bian, ZM, Till, GO, Petty, HR and Elner, VM (2007). Proinflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res 95: 462-472.
7. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 36: 1271-1279.
8. Droge, W (2002). Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
9. Balaban, RS, Nemoto, S and Finkel, T (2005). Mitochondria, oxidants, and aging. Cell 120: 483-495.
10. Schrader, M and Fahimi, HD (2004). Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 122: 383-393.
11. Thannickal, VJ and Fanburg, BL (2000). Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028.
12. Babior, BM (2004). NADPH oxidase. Curr Opin Immunol 16: 42-47.
13. Cross, AR and Segal, AW (2004). The NADPH oxidase of professional phagocytes - prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1-22.
14. Babior, BM (2000). The NADPH oxidase of endothelial cells. IUBMB Life 50: 267-269.
15. Gorlach, A, Brandes, RP, Nguyen, K, Amidi, M, Dehghani, F and Busse, R (2000). A gp91 phox containing NADPH oxidase selectively expressed in enclothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32.
16. De Leo, FR, Ulman, KV, Davis, AR, Jutila, KL and Quinn, MT (1996). Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrom b to a common functional domain in p47phox. J Biol Chem 271: 17013-17020.
17. Segal, AW and Abo, A (11993). The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 18: 43-47.
18. Bedard, K and Krause, KH (2007). The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313.
19. Regier, DS, Greene, DG, Sergeant, S, Jesaitis, AJ and McPhail, LC (2000). Phosphorylation of p22phox is mediated by phospholipase D-dependent and -independent mechanisms. Correlation of NADPH oxidase activity and p22phox phosphorylation. J Biol Chem 275: 28406-28412.
20. Mori, K, Gehlbach, F, Yamamoto, 5, Duh, E, Zack, DJ, Li, Q et al. (2002). AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43: 1994-2000.
21. Esterbauer, H, Schaur, RJ and Zollner, H (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
22. Ischiropoulos, H, Zhu, L, Chen, J, Tsai, M, Martin, JC, Smith, CD et al. (1992). Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298: 431-437.
23. Bolk, D (1993). The retinal pigment epithelium: A versatile partner in vision. J Cell Sci Suppl 17: 189-195.
24. Rizzolo, LJ (1997). Polarity and the development of the outer blood-retinal barrier. Histol Histopothol 12: 1057-1067.
25. Kawahara, BT, Quinn, MT and Lambeth, JD (2007). Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol Biol 7: 109.
26. Griendling, KK, Sorescu, D, Ushio-Fukai, M (2000). NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494-501.
27. Ushio-Fukai, M and Alexander, RW (2004). Reactive oxygen species as mediators of angiogenesis signaling: Role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97.
28. Ushio-Fukai, M (2006). Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc Res 71: 226-235.
29. Ushio-Fukai, M (2007). VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 9: 731-739.
30. Kliffen, M, Sharma, HS, Mooy, CM, Kerkvliet, S and de Jong, PT (1997). Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81: 154-162.
31. Ryan, SJ (1982). Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol 100: 1804-1809.
32. Yi, X, Ogata, N, Komada, M, Yamamoto, C, Takahashi, K, Omori, K et al. (1997). Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235: 313-319.
33. Strauss, O (2005). The retinal pigment epithelium in visual function. Physiol Rev 85: 845-881.
34. Kent, D and Sheridan, C (2003). Choroidal neovascularization: A wound healing perspective. Mol Vis 9: 747-755.
35. Das, A and McGuire, PG (2003). Retinal and choraidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 22: 721-748.
36. Mousa, SA, Lorelli, W and Campochiaro, PA (1999). Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem 74: 135-143.
37. Infanger, DW, Sharma, RV and Davisson, RL (2006). NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid Redox Signal 8: 1583-1596.
38. Kamnsler, A and Segal, M (2004). Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29: 167-178.
39. Zimmerman, MC, Lazartigues, E, Lang, JA, Sinnayah, P, Ahmad, IM, Spitz, DR et al. (2002). Superoxide mediates the actions of angiatensin II in the central nervous system. Circ Res 91: 1038-1045.
40. Lambeth, JD (2004). NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189.
41. Li, JM and Shah, AM (2004). Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287: R1014-R1030.
42. Cacicedo, JM, Benjachareowong, S, Chou, E, Ruderman, NB and Ido, Y (2005). Palmitate-induced apoptosis in cultured bovine retinal pericytes: Roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 54: 1838-1845.
43. Manea, A, Raicu, M and Simionescu, M (2005). Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: Effect of angiotensin II and high glucose. Biol Cell 97: 723-734.
44. Ellis, EA, Grant, MB, Murray, FT, Wachowski, MB, Gulberski, DL, Kubilis, PS et al. (1998). Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24: 111-120.
45. Al-Shabrawey, M, Bartoli, M, El-Bemessy, AB, Platt, DH, Matragoon, S, Behzadian, MA et al. (2005). Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167 599-607.
46. Saito, Y, Geisen, P, Uppal, A and Hartnett, ME (2007). Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis 13: 840-853.
47. Rodrigues, EB (2007). Inflammation in dry age-related macular degeneration. Ophthalmologica 221: 143-152.
48. Heyworth, PG, Cross, AR and Curnutte, JT (2003). Chronic granulomatous disease. Curr Opin Immunol 15: 578-584.
49. Goldblatt, D, Butcher, J, Thrasher, AJ and Russell-Eggitt, I (1999). Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr 134: 780-783.
50. Kim, SJ, Kim, JG and Yu, YS (2003). Chorioretinal lesions in patients with chronic granulomatous disease. Retina 23: 360-365.